Describe the metabolism of phenylalanine and tyrosine. Discuss the disorders arising from blocks in this pathway.
Introduction
Phenylalanine is an essential aromatic amino acid. Tyrosine is semi-essential — it can be made from phenylalanine, but becomes essential if that conversion fails.
- Both are glucogenic and ketogenic
The Central Reaction
Phenylalanine → Phenylalanine hydroxylase — needs tetrahydrobiopterin (BH4) and O2 → tyrosine
- Irreversible — tyrosine cannot make phenylalanine
- BH4 is regenerated by dihydropteridine reductase
- The same cofactor is needed by tyrosine hydroxylase and tryptophan hydroxylase — which is why BH4 defects are so damaging
Fates of Tyrosine
| Product | Pathway | Site |
|---|---|---|
| Catecholamines | Tyrosine → dopa → dopamine → noradrenaline → adrenaline | Adrenal medulla, sympathetic neurones, brain |
| Melanin | Tyrosine → dopa → dopaquinone → melanin (tyrosinase) | Melanocytes |
| Thyroid hormones | Iodination of tyrosine on thyroglobulin | Thyroid |
| Complete degradation | Tyrosine → homogentisate → fumarate + acetoacetate | Liver |
Degradation Pathway
Tyrosine → Tyrosine transaminase → p-Hydroxyphenylpyruvate → p-Hydroxyphenylpyruvate dioxygenase → homogentisate → homogentisate oxidase → Maleylacetoacetate → Fumarylacetoacetate → fumarate (glucogenic) + acetoacetate (ketogenic)
Disorders — Where Each Block Lies
| Disorder | Enzyme deficient | Accumulates | Key features |
|---|---|---|---|
| Phenylketonuria | Phenylalanine hydroxylase | Phenylalanine, phenylpyruvate | Mental retardation, mousy odour, fair skin, eczema, seizures |
| Tyrosinaemia type I | Fumarylacetoacetate hydrolase | Succinylacetone | Liver failure, renal tubular defect, cabbage-like odour |
| Tyrosinaemia type II | Tyrosine transaminase | Tyrosine | Corneal ulcers, palmar keratosis |
| Alkaptonuria | Homogentisate oxidase | Homogentisic acid | Urine darkens on standing, ochronosis, arthritis |
| Albinism | Tyrosinase | — (melanin not formed) | White skin and hair, photophobia, nystagmus, skin cancer risk |
CLINICAL PEARL
The pattern is worth learning as a sequence: a block early in the pathway (PKU) causes the substrate to spill into abnormal routes; a block late (alkaptonuria) causes accumulation of a pigmented intermediate; a block in a branch (albinism) causes loss of the product only.
Phenylketonuria in Detail
Phenylalanine hydroxylase deficient → Phenylalanine accumulates (> 20 mg/dL; normal 1–2) → Diverted to transamination → Phenylpyruvate, phenyllactate, phenylacetate → Excreted in urine — phenylacetate gives the mousy odour → Phenylalanine competes for the amino acid transporter at the blood–brain barrier → Impaired brain development → mental retardation
- Fair skin and hair — excess phenylalanine inhibits tyrosinase, so melanin falls
- Incidence about 1 in 10,000; autosomal recessive
- Guthrie bacterial inhibition test or tandem mass spectrometry on a heel prick, taken after 48–72 hours of milk feeding
- Treatment — a low phenylalanine diet started within the first weeks of life, continued at least through childhood
- Aspartame must be avoided — it is a phenylalanine-containing dipeptide
- Malignant PKU — defect in BH4 synthesis or in dihydropteridine reductase; diet alone does not help because catecholamine and serotonin synthesis also fail. Needs BH4, L-dopa and 5-hydroxytryptophan
Catecholamine Synthesis and Degradation
Tyrosine → Tyrosine hydroxylase (BH4) — rate-limiting → dopa → dopa decarboxylase (PLP) → dopamine → Dopamine β-hydroxylase (vitamin C, copper) → noradrenaline → PNMT (SAM; induced by cortisol) → adrenaline
- Degraded by MAO and COMT → excreted as VMA and metanephrines
- Dopamine in the brain is degraded to homovanillic acid (HVA)
- Urinary VMA is the screening test for phaeochromocytoma; HVA and VMA for neuroblastoma
Melanin and Thyroid Hormone
- Melanin — tyrosine → dopa → dopaquinone → eumelanin (brown-black) or phaeomelanin (red-yellow, requires cysteine). Enzyme: tyrosinase, a copper enzyme
- Thyroid hormone — tyrosine residues on thyroglobulin are iodinated to MIT and DIT, then coupled to T3 and T4
Applied Aspects
- Maternal PKU — a treated woman who abandons the diet in pregnancy exposes the fetus to high phenylalanine → microcephaly, congenital heart disease and retardation even in a genetically normal baby. Strict dietary control must resume before conception
- Alkaptonuria is usually harmless in childhood; the ochronotic arthritis of the spine and large joints appears after 30. Urine darkens on standing or on adding alkali
- Albinism — the lack of melanin means no protection from ultraviolet light; skin cancer and visual defects are the real dangers
- Newborn screening for PKU is one of the great successes of preventive medicine — a cheap test that prevents irreversible retardation
- Tyrosinaemia type I — treated with nitisinone, which blocks the pathway higher up and prevents the toxic intermediate; a rare example of treating a metabolic block by creating another
- Parkinson disease — loss of nigral dopamine; treated with L-dopa, which crosses the blood–brain barrier whereas dopamine does not
- Carbidopa inhibits peripheral dopa decarboxylase, so more L-dopa reaches the brain and nausea is reduced
- α-Methyldopa produces a false neurotransmitter and was widely used as an antihypertensive in pregnancy
- Vitiligo — acquired autoimmune destruction of melanocytes; distinct from albinism, which is congenital and enzymatic
- Copper deficiency impairs tyrosinase and gives hypopigmented hair, as in Menkes disease
- Maple syrup urine disease — branched-chain α-keto acid dehydrogenase deficiency; sweet-smelling urine, ketoacidosis and neurological damage. It uses the same five coenzymes as the PDH complex
- Hartnup disease — defective tryptophan transport → a pellagra-like rash, since tryptophan is a precursor of niacin
- Carcinoid syndrome — the tumour diverts tryptophan to serotonin → may cause pellagra as well as flushing and diarrhoea
- Tandem mass spectrometry detects more than thirty inborn errors from a single dried blood spot — the modern basis of newborn screening
- Levodopa-induced dyskinesia limits long-term treatment of Parkinson disease and reflects pulsatile rather than continuous dopamine stimulation
All questions in Amino Acid & Protein Metabolism
- Q1Describe the urea cycle with its reactions, site and energetics. Explain its regulation and add a note on the urea cycle disorders. ★
- Q2Describe transamination and deamination. Explain the sources, transport and disposal of ammonia in the body. ★
- Q3Describe the metabolism of phenylalanine and tyrosine. Discuss the disorders arising from blocks in this pathway. ★
- Q4Describe the metabolism of methionine and cysteine. Explain transmethylation, the role of SAM, and the methyl trap hypothesis. ★
- Q5Define nitrogen balance. Describe protein turnover and protein quality. Compare kwashiorkor with marasmus. ★
- SN1Define transamination. Describe its mechanism, significance and clinical applications. ★
- SN2Define hyperammonaemia. Describe its causes, the basis of ammonia toxicity, and its management. ★
- SN3Write a short note on phenylketonuria. ★
- SN4Describe alkaptonuria and albinism with their biochemical basis. ★
- SN5Describe the structure, synthesis and functions of glutathione. ★
- SN6Write a short note on homocystinuria. Differentiate it from Marfan syndrome. ★
- SN7Describe the synthesis and significance of creatine and creatinine. ★